Small Technologies
BIG IMPACT
Established in 2016 within the Koch Institute for Integrative Cancer Research, the Marble Center is the first virtual nanomedicine center at MIT dedicated to tackling grand challenges in cancer detection, treatment, and monitoring with a focus on miniaturization and convergence —the blending of the life and physical sciences with engineering.
Dr. Bob Langer awarded the 2024 Kavli nanoscience prize
Dr. Michael Birnbaum joins the Marble Center faculty
Announcing the winners of the 2024 Marble Center Poster symposium
The Marble Center presents exciting new technologies at the White House Technology Demo!
New Cancer Vaccines Could Treat Some Types of Pancreatic, Colorectal and Other Deadly Forms of the Disease
MIT-led team receives funding to pursue new treatments for metabolic disease
Intercepting ovarian cancer: Panel discussion with Professors Angela Belcher, Sangeeta Bhatia, and Paula Hammond.
Endpoints News names Sangeeta Bhatia named one of 20 women reshaping biopharma in 2023 her efforts to help women in academia launch startups.
Funding to Daniel Anderson’s lab will advance research on new delivery technology for RNA vaccines and therapies
Decades after breakthrough, scientists still puzzling over mRNA delivery
Dr. Bob Langer sits with Genetic Engineering & Biotechnology News to talk about the future of mRNA vaccines.
Dr. Angela Belcher Commands a Virus to Hunt a Deadly Cancer. Illustration by Agata Nowicka.
Making deeper Inroads against ovarian cancer at the Marble Center for Cancer Nanomedicine. Photo credit: Paulo Campos.
Paula Hammond wins faculty’s Killian Award
Small Sciences
It’s in our DNA
Marble Center researchers work at the molecular level to devise technologies for the early detection of cancer, develop new drugs and drug delivery combinations that invade and selectively destroy tumor cells, and harness the immune system to fight cancer even as it evolves. Learn more about latest research here.
Our Community
Find out about our efforts to promote convergence science.